Physician profile
Robert Whitmore
NPI 1669521068
$25,086.04
in general payments reported to CMS, 2019-2025
6 companies · $4,121 in 2025
The $4,121 reported for 2025 was more than what 78% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $181 · 2022: $4,323 · 2023: $1,114 · 2024: $15K · 2025: $4,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $1,692 · Food and Beverage: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,717.50 |
| Travel and Lodging | $1,691.50 |
| Food and Beverage | $1,173.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $16,991.81 | 2022-2025 | |
| Intrinsic Therapeutics | $5,100.00 | 2024-2025 | Barricaid Acd (Annular Closure Device) |
| Medical Device Business Services, INC. | $1,983.03 | 2023-2024 | Spine & Trauma 3d Navigation, Expedium |
| Depuy Synthes Sales INC. | $908.79 | 2021-2025 | Teligen, Conduit, Symphony |
| Medtronic, INC. | $102.41 | 2023-2024 | Stealthstation S8 Platform |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Whitmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.